UnitedHealth Group (UNH) abruptly canceled its Investor Day presentation shortly after it began this morning following media reports that the CEO of its insurance unit had been fatally shot.
Brian Thompson, who had led UNH's insurance segment since 2021, was shot in midtown Manhattan around 6:45 am Eastern Time on Wednesday morning, according to CNBC. He was transported to a local hospital in critical condition but was pronounced dead shortly thereafter.
UNH's Investor Day presentation had begun at 8:00 am Eastern Time in New York City, but quickly came to a close.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
"I'm afraid that we – some of you may know we're dealing with a very serious medical situation with one of our team members," UnitedHealth Group staff said during the presentation, according to the transcript obtained by CNBC. "And as a result, I'm afraid we’re going to have to bring to a close the event today, which I'm sure you'll understand."
Ahead of the presentation, UNH provided its outlook for fiscal 2025, calling for revenue in the range of $450 billion to $455 billion and earnings per share between $29.50 to $30.00.
"Overall, the outlook is in-line with expectations and represents a solid starting point for a company that guides conservatively, though the devil will be in the details," said Oppenheimer analyst Michael Wiederhorn, who has an Outperform (Buy) rating on the Dow Jones stock.
Where does Wall Street stand on UnitedHealth?
In fact, most of Wall Street is already bullish on the blue chip stock, even as its lagged the broad market this year. Indeed, shares of UNH are up 16% since the start of 2024 on a total return basis (price change plus dividends) basis vs the S&P 500's 28.5% gain.
According to S&P Global Market Intelligence, the average analyst target price for UNH stock is $629.19, representing implied upside of nearly 3% to current levels. Additionally, the consensus recommendation is Strong Buy.
Financial services firm UBS Global Research is one of the more bullish outfits on UNH stock with a Buy rating and $650 price target.
"Following the election, a Trump presidency is likely to be favorable to Medicare Advantage with higher rate updates and less regulation," says UBS analyst AJ Rice. "This puts UNH at the forefront to benefit the most as it gains market share in 2025 while remaining in its target margin range for MA. Additionally, a Republican administration is likely to be more lenient towards anti-trust, allowing UNH to have more acquisition opportunities long term."
Related Content
-
‘Are You Better Off Than You Were 71 Days Ago?’ Cory Booker Marathon Senate Speech Highlights Tax DebateTax Policy A speech protesting Trump’s policies, including tax plans, breaks U.S. Senate records.
-
Stock Market Today: Stocks Are Mixed Before Liberation DayMarkets are getting into the freewheeling rhythm of a second Trump administration.
-
Stock Market Today: Stocks Are Mixed Before Liberation DayMarkets are getting into the freewheeling rhythm of a second Trump administration.
-
How to Invest in SportsIf it's springtime, Forbes is out with its annual list of baseball franchise values. The billions involved might make you wonder how to invest in sports.
-
Winning Strategies for Financial Advisers as Clients' Lives EvolveHow can the wealth management industry help make life transitions easier for the adviser and the client?
-
How Advisers Can Establish Relationships With HNW ProspectsThese strategies can help to build influence with high-net-worth individuals, who are often looking to an adviser for insight rather than solutions.
-
When Your Car Is Fixed, But You've Still Got the ProblemThis reader's experience with trying to get squealing brakes fixed under an extended warranty mirrors what others are experiencing these days.
-
Stock Market Today: Dow Rises 854 Points From Its Intraday LowIf there's one thing markets hate, it's uncertainty. But uncertainty is all they're getting these days.
-
Seven Questions to Ask When Evaluating Personal Loan OptionsTaking out a personal loan too hastily could lock you into unfavorable terms with an untrustworthy lender. Ask these questions before signing anything.
-
How Much Does Being Rich Matter in Retirement?After a certain point, having more money in retirement won't make you any happier, new research shows. Instead, physical health, a sense of purpose, and a minimal amount of non-mortgage debt are more relevant.
